NEW YORK, August 7, 2026, 14:14 EDT — Nasdaq opens trading.
- Shares of VisionSys rose 16.4% to $3.55, after reaching a high of $7.97. Trading volume was six times higher than the 65-day average.
- An upcoming placement valued at $91.75 million involves 50 million ADSs at an implied price of $1.835 per share.
- Initial full-close estimates show buyers hold 94.7% of the expanded Class A share pool.
Shares of VisionSys AI Inc. NASDAQ:VSA surged on Friday before pulling back much of the advance. The company’s American depositary shares started the session at $3.03 and hit a high of $7.97. By later in the session, they were last changing hands at $3.55, holding onto just 10% of their maximum gain.
| Metric | Friday reading | Comparison |
|---|---|---|
| Price at 14:06 EDT | $3.55 | +16.39% |
| Intraday high | $7.97 | +161.31% against Thursday’s close |
| Peak dollar gain retained | $0.50 of $4.92 | 10.2% |
| Volume | 2,783,378 | 6.03 times the 65-day average |
| Russell 2000 | +0.99% | VSA topped by 15.40 points |
Trading ratios are derived by calculating the quoted price, volume, and benchmark information.
No new corporate statement appeared in the monitored feeds. The latest press release remained May 20. The newest SEC submission carried a July 10 date.
The July filing represents the key investor event. VisionSys has committed to selling 125 billion Class A shares for approximately $91.75 million. The deal is anticipated to close in the third quarter, pending conditions.
One ADS currently stands for 2,500 Class A shares. The offering totals 50 million ADSs, priced at $1.835 apiece. This figure marks a 48.3% discount to Friday’s $3.55 closing quote.
| Class A measure | Existing at June 1 | Proposed addition | Preliminary pro forma |
|---|---|---|---|
| Ordinary shares | 6.975 billion | 125.000 billion | 131.975 billion |
| ADS-equivalent shares | 2.790 million | 50.000 million | 52.790 million |
| Size relative to current amount | 1.0 times | 17.9 times | 18.9 times |
| Share of economic ownership | 100% legacy holders | — | Purchasers 94.7%; legacy 5.3% |
| ADS-equivalent pricing | Market: $3.55 | Placement: $1.835 | Discount to placement: 48.3% |
The pro-forma data is based on the assumption of complete closing, no additional issuance, and a constant ADS ratio of 2,500-to-one.
The change in ownership would be significant. Placement buyers would take 94.7% of the expanded Class A group, while current Class A investors would keep roughly 5.3%.
The pool of listed shares is exceptionally limited. As of June 1, about 1.40 billion Class A shares were held as ADSs, which translated to approximately 560,210 ADSs based on the existing ratio. StockAnalysis currently lists 621,510 outstanding shares, making Friday’s trading volume 4.5 times that figure.
Market capitalization estimates are inconsistent. The vendor’s calculation puts VisionSys at about $2.21 million with a price of $3.55. Turning all June Class A shares into ADS equivalents results in a value of $9.90 million. The placement is significantly larger than both.
| Reference base | Reported or calculated value | $91.75 million proceeds divided by base |
|---|---|---|
| Market value reported by vendor | $2.21 million | 41.6 times |
| All Class A shares as of June, ADS-adjusted | $9.90 million | 9.3 times |
| Ongoing revenue for 2025 | $149,000 | 615.8 times |
| Absolute value of 2025 operating loss | $5.717 million | 16.0 times |
| Cash from continuing operations at year-end | $7.643 million | 12.0 times |
Gross proposed proceeds and figures from continuing operations reported in the annual report are used for financial comparisons.
VisionSys is still in the initial stages of its operating business. In 2025, the company posted $149,000 in revenue from continuing operations. Losses from continuing operations totaled $5.73 million, while year-end cash stood at $7.64 million. Net income was $245.8 million, reflecting gains from discontinued operations and a disposal.
The firm has left the education sector and now concentrates solely on brain-computer-interface technology. In April, an early-stage funding proposal aimed to support BCI research, product launches and general working capital. The July deal did not disclose a revised allocation timeline.
Sell-side insights remain limited. The WSJ market-data feed reports just a single Buy rating. StockAnalysis shows neither analysts nor target prices. MarketScreener’s sole brokerage mention is from June 2023.
| Recommendation feed | Displayed view | Named date or analyst | Investor read-through |
|---|---|---|---|
| WSJ market data | Single Buy; no alternative ratings | Analyst unnamed | Single data point |
| StockAnalysis | No analyst ratings; no target provided | Not shown | Lacks consensus |
| MarketScreener history | Buy call; $8 price target | EF Hutton, June 14, 2023 | Historic Tarena analyst opinion |
The records reviewed did not show any 2026 brokerage recommendation by name.
The EF Hutton note addressed the company’s previous Tarena operations. It was issued before the shift to BCI and the subsequent reverse ADS split. The examined filings did not include any specific analyst or executive remarks on Friday’s actions.
Risks are still significant. The offering is subject to conditions and could be settled in cryptocurrency at VisionSys’ option. Completing the deal would substantially dilute the June Class A base. The small ADS base further increases volatility in the share price.
Investors are seeking confirmation on closing proceeds, method of payment, and the ultimate share count. For now, execution of funding outweighs the significance of Friday’s intraday peak.



